Homozygous SCN2A gene mutation causing early infantile epileptic encephalopathy: The second case in literature

Main Article Content

Hale Önder Yılmaz

Abstract

Objective: Early infantile epileptic encephalopathy type11 (EIEE) generally known as an autosomal dominant inherited disease caused by the voltage-gated sodium channel neuronal type 2 alpha subunit (Navα1.2) encoded by the SCN2A gene mutations. The clinic of the disease is variable. Herein we report the second case with a homozygous missense mutation of the SCN2A gene (c.1588 G>T).


Material and methods: NGS gene panel including the SCN2A gene from genomic DNA extracted from peripheral blood using a commercially available kit and quantified using standard methods. Illumina miseq analysis platform was used for this purpose, we performed analysis of coding regions and exon-intron boundaries and the data was analyzed by IGV.


Results: The results confirmed by sanger sequencing show us an SCN2A (NM_001040142) c.1588 G>T homozygote mutation.


Conclusion: This shows us more clinical and molecular studies need for SCN2A associated disease pathogenesis

Downloads

Download data is not yet available.

Article Details

How to Cite
Yılmaz, H. Önder. (2019). Homozygous SCN2A gene mutation causing early infantile epileptic encephalopathy: The second case in literature. Medical Science and Discovery, 6(9), 221-223. https://doi.org/10.36472/msd.v6i9.302
Section
Case Reports

References

1. Shevell MI, Sinclair D, Metrakos K. Benign familial neonatal seizures: clinical and electroencephalographic characteristics. Pediatric neurology. 1986;2(5):272-5.

2. Berkovic SF, Heron SE, Giordano L, Marini C, Guerrini R, Kaplan RE, et al. Benign familial neonatal‐infantile seizures: characterization of a new sodium channelopathy. Annals of neurology. 2004;55(4):550-7.

3. Kaplan RE, Lacey DJ, Opitz JM. Benign familial neonatal‐infantile seizures. American journal of medical genetics. 1983;16(4):595-9.

4. Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. Journal of Neuroscience. 2004;24(11):2690-8.

5. Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, et al. De novo mutations of voltage-gated sodium channel αII gene SCN2A in intractable epilepsies. Neurology. 2009;73(13):1046-53.

6. Liao Y, Anttonen A-K, Liukkonen E, Gaily E, Maljevic S, Schubert S, et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology. 2010;75(16):1454-8.

7. Hackenberg A, Baumer A, Sticht H, Schmitt B, Kroell-Seger J, Wille D, et al. Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De Novo missense mutation in the SCN2A gene. Neuropediatrics. 2014;45(04):261-4.

8. Baasch AL, Hüning I, Gilissen C, Klepper J, Veltman JA, Gillessen‐Kaesbach G, et al. Exome sequencing identifies a de novo SCN 2 A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Epilepsia. 2014;55(4):e25-e9.

9. AlSaif S, Umair M, Alfadhel M. Biallelic SCN2A Gene Mutation Causing Early Infantile Epileptic Encephalopathy: Case Report and Review. Journal of central nervous system disease. 2019;11:1179573519849938.